SNCA and Parkinson disease: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by two hallmarks: (i) loss of dopaminergic neurons in the substantia nigra (SN) of the brain responsible for the motor features1 and (ii) excess accumulation of aggregated α-synuclein (α-syn) protein2.